JavaScript is disabled in your browser. enable it to enjoy the full features of Tracxn.

Want to know more about Life Sciences?

Life Sciences companies globally

Sector Definition: Companies providing disease specific and disease agnostic therapy, diagnostic solutions, drugs, and life science R7D. Life Sciences sector is also known as Biotech or Biological Sciences.

Sector Definition: Companies providing disease specific and disease agnostic therapy, diagnostic solutions, drugs, and life science R7D. Life Sciences sector is also known as Biotech or Biological Sciences.

Companies in Life Sciences

There are 56,057 companies in Life Sciences which include Biogen, 23andMe, Dexcom, Medidata, Intuitive. 25,937 companies in Life Sciences are funded, with 13,461 having secured Series A funding. Till date, the sector has seen the creation of 71 Unicorns. United States has the most number of companies in Life Sciences (24,585), followed by United Kingdom (3,470), and then China (3,007).
2024 has seen the creation of 226 Life Sciences companies. On average, the last 10 years have seen 2,434 new companies launched every year. Most number of Life Sciences startups have been founded by alumni from Harvard University, Massachusetts Institute of Technology and Stanford University.

Here is a List of top 10 companies in Life Sciences

Developer of therapies for neurodegenerative and immunology disorders. The company has developed a pipeline of drugs for Alzheimer's disease Amyotrophic lateral sclerosis (ALS), Angelman syndrome, Brain contusion, Multiple sclerosis (MS), Multiple system atrophy (MSA), Ophthalmology, Pain, and more.

Key facts about Biogen

Provider of genetic test solutions to study ancestry, genealogy, and inherited traits. The platform provides a study regarding an individual's ancestry, genealogy, and inherited traits. The company also markets its data is categorized and searchable form to researchers and scientists.

Key facts about 23andMe

Provider of a wearable device for glucose monitoring. It provides a wearable patch that enables users to measure glucose levels in real-time. It has the capability to send data wirelessly to a display device through a transmitter and the touch screen receiver displays real-time glucose data. In 2022, the company recorded annual revenues of $3.02B and a net profit of $0.29B.

Key facts about Dexcom

AI-based clinical trial management software for researchers. It offers a platform for data analysis, research experiment protocol designing, trail planning, supply, clinical management, and data management among others. The company has developed products such as CATIA R2021x, 3DEXPERIENCE, ENOVIA, BIOVIA, and more which assist with the drug discovery process.

Key facts about Medidata

  • Founded Year: 1999
  • Location: New York City (United States)
  • Stage: Acquired
  • Total Funding till date: $21.5M
  • Investors: TFS, Insight Partners and 11 Others
  • Latest Funding Round: Unattributed, Nov 06, 2023
  • Tracxn Score: 85/100 What is this?
  • Competitors Rank: 1 of 307 Competitors
Developer of robotic-assisted surgical systems. It offer Vinci Surgical System that is used in minimally invasive surgical procedures across various medical specialties, including urology, gynecology, general surgery, and cardiothoracic surgery.

Key facts about Intuitive

Withings provides solutions for health monitoring, sleep monitoring, activity monitoring and home environment monitoring. Withings provides computing and storage resources for app building. Its product, Wifi BodyScale can measure both weight and fat mass and upload the data to the cloud over wi-fi. Withings home is a video monitoring and security. Withings Thermo, a WiFi connected thermometer, measures temperature from the temporal artery on the die of the head. The company plans to launch the device for $99.95. The connected app will be available for iOS and Android devices.

Key facts about Withings

  • Founded Year: 2008
  • Location: Moulineaux (France)
  • Stage: Acquired
  • Total Funding till date: $93.8M
  • Investors: Bpifrance, Idinvest Partners and 8 Others
  • Latest Funding Round: Series B, Jul 28, 2020, $60M
  • Tracxn Score: 82/100 What is this?
  • Competitors Rank: 1 of 1,964 Competitors
Developer of Invisalign clear aligners and other dental products. The products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services for dental professionals. Invisalign is the combination of virtual modeling software, manufacturing process, customization, and custom-made aligners.

Key facts about Align Technology

Tandem Diabetes is a developer of devices for continuous glucose monitoring and manual insulin delivery. It develops insulin pumps & other products and services that bring innovation, convenience & style to diabetes management. The first product, the t: slim Insulin Pump, features a sleek, modern design, intuitive touch-screen interface, and a rechargeable lithium-polymer battery. The company claims that this makes them closer to producing a fully automated closed-loop automated insulin delivery device that will not require human intervention to release insulin.

Key facts about Tandem Diabetes

Developer of cell lines with genetic modification using AAV gene-editing platform. The company has cell line engineering, knockout cell lines, and reporter cell lines. It also provides services in T cell activation assay, lymphocyte reaction assay, T cell-mediated tumor cell lysis assay, ADCC, and CDC assays, gene-editing for immuno-oncology, CRISPR Screening, drug combination screening, in vitro assay, and in-vivo assay.

Key facts about Horizon Discovery

  • Founded Year: 2007
  • Location: Cambridge (United Kingdom)
  • Stage: Acquired
  • Total Funding till date: $46.3M
  • Investors: DFJ, MVM and 13 Others
  • Latest Funding Round: Post IPO, Sep 07, 2018
  • Tracxn Score: 80/100 What is this?
  • Competitors Rank: 1 of 44 Competitors
Developer of targeted and immune-oncology drugs against cancer. The company's product pipeline includes oral small molecule inhibitors and monoclonal antibodies, such as BGB-3111, an oral inhibitor of Bruton tyrosine kinase, BGB-283, a B-RAF inhibitor; and BGB-290, a poly (ADP-ribose) polymerase inhibitor. Also, has another candidate BGB-108, a potentially differentiated PD-1 monoclonal antibody candidate.

Key facts about BeiGene